0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global POC Infectious Diseases Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-19Q2979
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global POC Infectious Diseases Market Insights and Forecast to 2028
BUY CHAPTERS

Global POC Infectious Diseases Market Research Report 2025

Code: QYRE-Auto-19Q2979
Report
August 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

POC Infectious Diseases Market

The global market for POC Infectious Diseases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
This report aims to provide a comprehensive presentation of the global market for POC Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Infectious Diseases.
The POC Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POC Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of POC Infectious Diseases Market Report

Report Metric Details
Report Name POC Infectious Diseases Market
Segment by Type
  • Flu
  • Adenovirus
  • Malaria
  • Streptococcal Bacteremia
  • Tuberculosis (TB)
  • Occult Blood
  • HIV
Segment by Application
  • Hospital& Clinics
  • Clinical Diagnostic Laboratories
  • Homecare Settings
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad, Cepheid, Diamedix, Diasorin, Eiken Chemical, Enzo Biochem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of POC Infectious Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the POC Infectious Diseases Market report?

Ans: The main players in the POC Infectious Diseases Market are Abbott, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad, Cepheid, Diamedix, Diasorin, Eiken Chemical, Enzo Biochem

What are the Application segmentation covered in the POC Infectious Diseases Market report?

Ans: The Applications covered in the POC Infectious Diseases Market report are Hospital& Clinics, Clinical Diagnostic Laboratories, Homecare Settings

What are the Type segmentation covered in the POC Infectious Diseases Market report?

Ans: The Types covered in the POC Infectious Diseases Market report are Flu, Adenovirus, Malaria, Streptococcal Bacteremia, Tuberculosis (TB), Occult Blood, HIV

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Flu
1.2.3 Adenovirus
1.2.4 Malaria
1.2.5 Streptococcal Bacteremia
1.2.6 Tuberculosis (TB)
1.2.7 Occult Blood
1.2.8 HIV
1.3 Market by Application
1.3.1 Global POC Infectious Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital& Clinics
1.3.3 Clinical Diagnostic Laboratories
1.3.4 Homecare Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global POC Infectious Diseases Market Perspective (2020-2031)
2.2 Global POC Infectious Diseases Growth Trends by Region
2.2.1 Global POC Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 POC Infectious Diseases Historic Market Size by Region (2020-2025)
2.2.3 POC Infectious Diseases Forecasted Market Size by Region (2026-2031)
2.3 POC Infectious Diseases Market Dynamics
2.3.1 POC Infectious Diseases Industry Trends
2.3.2 POC Infectious Diseases Market Drivers
2.3.3 POC Infectious Diseases Market Challenges
2.3.4 POC Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POC Infectious Diseases Players by Revenue
3.1.1 Global Top POC Infectious Diseases Players by Revenue (2020-2025)
3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2020-2025)
3.2 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by POC Infectious Diseases Revenue
3.4 Global POC Infectious Diseases Market Concentration Ratio
3.4.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2024
3.5 Global Key Players of POC Infectious Diseases Head office and Area Served
3.6 Global Key Players of POC Infectious Diseases, Product and Application
3.7 Global Key Players of POC Infectious Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 POC Infectious Diseases Breakdown Data by Type
4.1 Global POC Infectious Diseases Historic Market Size by Type (2020-2025)
4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2026-2031)
5 POC Infectious Diseases Breakdown Data by Application
5.1 Global POC Infectious Diseases Historic Market Size by Application (2020-2025)
5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America POC Infectious Diseases Market Size (2020-2031)
6.2 North America POC Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America POC Infectious Diseases Market Size by Country (2020-2025)
6.4 North America POC Infectious Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size (2020-2031)
7.2 Europe POC Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe POC Infectious Diseases Market Size by Country (2020-2025)
7.4 Europe POC Infectious Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size (2020-2031)
8.2 Asia-Pacific POC Infectious Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific POC Infectious Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific POC Infectious Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size (2020-2031)
9.2 Latin America POC Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America POC Infectious Diseases Market Size by Country (2020-2025)
9.4 Latin America POC Infectious Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size (2020-2031)
10.2 Middle East & Africa POC Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa POC Infectious Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa POC Infectious Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Infectious Diseases Introduction
11.1.4 Abbott Revenue in POC Infectious Diseases Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Details
11.2.2 Meridian Bioscience Business Overview
11.2.3 Meridian Bioscience POC Infectious Diseases Introduction
11.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2020-2025)
11.2.5 Meridian Bioscience Recent Development
11.3 Orasure Technologies
11.3.1 Orasure Technologies Company Details
11.3.2 Orasure Technologies Business Overview
11.3.3 Orasure Technologies POC Infectious Diseases Introduction
11.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2020-2025)
11.3.5 Orasure Technologies Recent Development
11.4 Trinity Biotech
11.4.1 Trinity Biotech Company Details
11.4.2 Trinity Biotech Business Overview
11.4.3 Trinity Biotech POC Infectious Diseases Introduction
11.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2020-2025)
11.4.5 Trinity Biotech Recent Development
11.5 Beckman Coulter/ Danaher
11.5.1 Beckman Coulter/ Danaher Company Details
11.5.2 Beckman Coulter/ Danaher Business Overview
11.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction
11.5.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2020-2025)
11.5.5 Beckman Coulter/ Danaher Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson POC Infectious Diseases Introduction
11.6.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2020-2025)
11.6.5 Becton Dickinson Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Details
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux POC Infectious Diseases Introduction
11.7.4 Biomerieux Revenue in POC Infectious Diseases Business (2020-2025)
11.7.5 Biomerieux Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Details
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad POC Infectious Diseases Introduction
11.8.4 Bio-Rad Revenue in POC Infectious Diseases Business (2020-2025)
11.8.5 Bio-Rad Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid POC Infectious Diseases Introduction
11.9.4 Cepheid Revenue in POC Infectious Diseases Business (2020-2025)
11.9.5 Cepheid Recent Development
11.10 Diamedix
11.10.1 Diamedix Company Details
11.10.2 Diamedix Business Overview
11.10.3 Diamedix POC Infectious Diseases Introduction
11.10.4 Diamedix Revenue in POC Infectious Diseases Business (2020-2025)
11.10.5 Diamedix Recent Development
11.11 Diasorin
11.11.1 Diasorin Company Details
11.11.2 Diasorin Business Overview
11.11.3 Diasorin POC Infectious Diseases Introduction
11.11.4 Diasorin Revenue in POC Infectious Diseases Business (2020-2025)
11.11.5 Diasorin Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical POC Infectious Diseases Introduction
11.12.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2020-2025)
11.12.5 Eiken Chemical Recent Development
11.13 Enzo Biochem
11.13.1 Enzo Biochem Company Details
11.13.2 Enzo Biochem Business Overview
11.13.3 Enzo Biochem POC Infectious Diseases Introduction
11.13.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2020-2025)
11.13.5 Enzo Biochem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global POC Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Flu
 Table 3. Key Players of Adenovirus
 Table 4. Key Players of Malaria
 Table 5. Key Players of Streptococcal Bacteremia
 Table 6. Key Players of Tuberculosis (TB)
 Table 7. Key Players of Occult Blood
 Table 8. Key Players of HIV
 Table 9. Global POC Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global POC Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global POC Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global POC Infectious Diseases Market Share by Region (2020-2025)
 Table 13. Global POC Infectious Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global POC Infectious Diseases Market Share by Region (2026-2031)
 Table 15. POC Infectious Diseases Market Trends
 Table 16. POC Infectious Diseases Market Drivers
 Table 17. POC Infectious Diseases Market Challenges
 Table 18. POC Infectious Diseases Market Restraints
 Table 19. Global POC Infectious Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global POC Infectious Diseases Market Share by Players (2020-2025)
 Table 21. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2024)
 Table 22. Ranking of Global Top POC Infectious Diseases Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by POC Infectious Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of POC Infectious Diseases, Headquarters and Area Served
 Table 25. Global Key Players of POC Infectious Diseases, Product and Application
 Table 26. Global Key Players of POC Infectious Diseases, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global POC Infectious Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global POC Infectious Diseases Revenue Market Share by Type (2020-2025)
 Table 30. Global POC Infectious Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global POC Infectious Diseases Revenue Market Share by Type (2026-2031)
 Table 32. Global POC Infectious Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global POC Infectious Diseases Revenue Market Share by Application (2020-2025)
 Table 34. Global POC Infectious Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global POC Infectious Diseases Revenue Market Share by Application (2026-2031)
 Table 36. North America POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America POC Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America POC Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe POC Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe POC Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific POC Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific POC Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific POC Infectious Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America POC Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America POC Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa POC Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa POC Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa POC Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Abbott Company Details
 Table 52. Abbott Business Overview
 Table 53. Abbott POC Infectious Diseases Product
 Table 54. Abbott Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 55. Abbott Recent Development
 Table 56. Meridian Bioscience Company Details
 Table 57. Meridian Bioscience Business Overview
 Table 58. Meridian Bioscience POC Infectious Diseases Product
 Table 59. Meridian Bioscience Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 60. Meridian Bioscience Recent Development
 Table 61. Orasure Technologies Company Details
 Table 62. Orasure Technologies Business Overview
 Table 63. Orasure Technologies POC Infectious Diseases Product
 Table 64. Orasure Technologies Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 65. Orasure Technologies Recent Development
 Table 66. Trinity Biotech Company Details
 Table 67. Trinity Biotech Business Overview
 Table 68. Trinity Biotech POC Infectious Diseases Product
 Table 69. Trinity Biotech Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 70. Trinity Biotech Recent Development
 Table 71. Beckman Coulter/ Danaher Company Details
 Table 72. Beckman Coulter/ Danaher Business Overview
 Table 73. Beckman Coulter/ Danaher POC Infectious Diseases Product
 Table 74. Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 75. Beckman Coulter/ Danaher Recent Development
 Table 76. Becton Dickinson Company Details
 Table 77. Becton Dickinson Business Overview
 Table 78. Becton Dickinson POC Infectious Diseases Product
 Table 79. Becton Dickinson Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 80. Becton Dickinson Recent Development
 Table 81. Biomerieux Company Details
 Table 82. Biomerieux Business Overview
 Table 83. Biomerieux POC Infectious Diseases Product
 Table 84. Biomerieux Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 85. Biomerieux Recent Development
 Table 86. Bio-Rad Company Details
 Table 87. Bio-Rad Business Overview
 Table 88. Bio-Rad POC Infectious Diseases Product
 Table 89. Bio-Rad Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 90. Bio-Rad Recent Development
 Table 91. Cepheid Company Details
 Table 92. Cepheid Business Overview
 Table 93. Cepheid POC Infectious Diseases Product
 Table 94. Cepheid Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 95. Cepheid Recent Development
 Table 96. Diamedix Company Details
 Table 97. Diamedix Business Overview
 Table 98. Diamedix POC Infectious Diseases Product
 Table 99. Diamedix Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 100. Diamedix Recent Development
 Table 101. Diasorin Company Details
 Table 102. Diasorin Business Overview
 Table 103. Diasorin POC Infectious Diseases Product
 Table 104. Diasorin Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 105. Diasorin Recent Development
 Table 106. Eiken Chemical Company Details
 Table 107. Eiken Chemical Business Overview
 Table 108. Eiken Chemical POC Infectious Diseases Product
 Table 109. Eiken Chemical Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 110. Eiken Chemical Recent Development
 Table 111. Enzo Biochem Company Details
 Table 112. Enzo Biochem Business Overview
 Table 113. Enzo Biochem POC Infectious Diseases Product
 Table 114. Enzo Biochem Revenue in POC Infectious Diseases Business (2020-2025) & (US$ Million)
 Table 115. Enzo Biochem Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. POC Infectious Diseases Picture
 Figure 2. Global POC Infectious Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global POC Infectious Diseases Market Share by Type: 2024 VS 2031
 Figure 4. Flu Features
 Figure 5. Adenovirus Features
 Figure 6. Malaria Features
 Figure 7. Streptococcal Bacteremia Features
 Figure 8. Tuberculosis (TB) Features
 Figure 9. Occult Blood Features
 Figure 10. HIV Features
 Figure 11. Global POC Infectious Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global POC Infectious Diseases Market Share by Application: 2024 VS 2031
 Figure 13. Hospital& Clinics Case Studies
 Figure 14. Clinical Diagnostic Laboratories Case Studies
 Figure 15. Homecare Settings Case Studies
 Figure 16. POC Infectious Diseases Report Years Considered
 Figure 17. Global POC Infectious Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global POC Infectious Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global POC Infectious Diseases Market Share by Region: 2024 VS 2031
 Figure 20. Global POC Infectious Diseases Market Share by Players in 2024
 Figure 21. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by POC Infectious Diseases Revenue in 2024
 Figure 23. North America POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America POC Infectious Diseases Market Share by Country (2020-2031)
 Figure 25. United States POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe POC Infectious Diseases Market Share by Country (2020-2031)
 Figure 29. Germany POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific POC Infectious Diseases Market Share by Region (2020-2031)
 Figure 37. China POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America POC Infectious Diseases Market Share by Country (2020-2031)
 Figure 45. Mexico POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa POC Infectious Diseases Market Share by Country (2020-2031)
 Figure 49. Turkey POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE POC Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 53. Meridian Bioscience Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 54. Orasure Technologies Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 55. Trinity Biotech Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 56. Beckman Coulter/ Danaher Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 57. Becton Dickinson Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 58. Biomerieux Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 59. Bio-Rad Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 60. Cepheid Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 61. Diamedix Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 62. Diasorin Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 63. Eiken Chemical Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 64. Enzo Biochem Revenue Growth Rate in POC Infectious Diseases Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart